PNC Financial Services Group
SNDX icon

PNC Financial Services Group’s Syndax Pharmaceuticals SNDX Stock Holding History

PNC Financial Services Group’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.6K Sell
2,085
-1
-0% -$21 ﹤0.01% 3398
2026
Q1 		$48.7K Buy
2,086
+7
+0.3% +$152 ﹤0.01% 3234
2025
Q4 		$43.7K Sell
2,079
-59
-3% -$1.03K ﹤0.01% 3287
2025
Q3 		$32.9K Buy
2,138
+1,634
+324% +$21.4K ﹤0.01% 3415
2025
Q2 		$4.72K Sell
504
-1,640
-76% -$18.1K ﹤0.01% 4161
2025
Q1 		$26.3K Buy
2,144
+233
+12% +$3.29K ﹤0.01% 3414
2024
Q4 		$25.3K Sell
1,911
-500
-21% -$8.56K ﹤0.01% 3424
2024
Q3 		$46.4K Buy
2,411
+902
+60% +$18.6K ﹤0.01% 3133
2024
Q2 		$31K Buy
1,509
+546
+57% +$11.4K ﹤0.01% 3273
2024
Q1 		$22.9K Sell
963
-15
-2% -$335 ﹤0.01% 3381
2023
Q4 		$21.1K Buy
978
+818
+511% +$12.6K ﹤0.01% 3400
2023
Q3 		$2.32K Buy
160
+62
+63% +$1.17K ﹤0.01% 4200
2023
Q2 		$2.05K Hold
98
– – ﹤0.01% 4374
2023
Q1 		$2.07K Hold
98
– – ﹤0.01% 4303
2022
Q4 		$2.49K Hold
98
– – ﹤0.01% 4197
2022
Q3 		$2K Hold
98
– – ﹤0.01% 4212
2022
Q2 		$2K Hold
98
– – ﹤0.01% 4239
2022
Q1 		$2K Hold
98
– – ﹤0.01% 4227
2021
Q4 		$2K Hold
98
– – ﹤0.01% 4186
2021
Q3 		$2K Hold
98
– – ﹤0.01% 4137
2021
Q2 		$2K Hold
98
– – ﹤0.01% 4055
2021
Q1 		$2K Buy
+98
New +$2.21K ﹤0.01% 3972
2018
Q4 		– Sell
-176
Closed -$1K – 4167
2018
Q3 		$1K Buy
+176
New +$1.25K ﹤0.01% 4059

Other funds holding SNDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

PNC Financial Services Group's SNDX Position: Q2 2026 in Review

PNC Financial Services Group reduced its Syndax Pharmaceuticals (SNDX) stake by 0.05% in Q2 2026, selling an estimated $21 and leaving 2,085 shares worth $45.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3398.

PNC Financial Services Group first reported a position in SNDX in Q3 2018 and has held it in 23 quarters since. The position peaked at $48.7K in Q1 2026. 73 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

  • PNC Financial Services Group held 2,085 shares of Syndax Pharmaceuticals worth $45.6K as of Q2 2026.
  • PNC Financial Services Group sold 1 Syndax Pharmaceuticals share in Q2 2026, an estimated $21.
  • Syndax Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3398 holding.
  • PNC Financial Services Group first reported a position in Syndax Pharmaceuticals in Q3 2018 and has held it in 23 quarters since.
  • PNC Financial Services Group's Syndax Pharmaceuticals position peaked at $48.7K in Q1 2026.
  • 73 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.